AMEX · ITDF
iShares LifePath Target Date 2050 ETF
$41.10-$0.60 (-1.44%)
iShares LifePath Target Date 2050 ETF’s quoted price sits in the upper half of its reported 52-week range, 4.31% below the high.
Loading market information…
AMEX · ITDE · USD
Stock price, dividends
Quote as of Oct 30, 2026, 07:59 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
iShares LifePath Target Date 2045 ETF’s quoted price sits in the upper half of its reported 52-week range, 3.71% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
iShares LifePath Target Date 2045 ETF’s forward annual dividend is $0.67 per share, paid annual. The forward yield is 1.69% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
THE COMPANY BEHIND THE TICKER
The iShares LifePath Target Date 2045 ETF is designed to help investors achieve their retirement objectives. It accomplishes this by investing in a diverse collection of other exchange-traded funds. A key feature is its dynamic adjustment of asset allocation, which automatically rebalances as the designated target year of 2045 draws nearer.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 31, 2026, 05:40 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
KEEP COMPARING
$41.10-$0.60 (-1.44%)
iShares LifePath Target Date 2050 ETF’s quoted price sits in the upper half of its reported 52-week range, 4.31% below the high.
$36.17$0.00 (0.0%)
Invesco Nasdaq Biotechnology ETF’s quoted price sits in the upper half of its reported 52-week range, 2.11% below the high.
$34.83-$0.22 (-0.62%)
iShares LifePath Target Date 2030 ETF’s quoted price sits in the upper half of its reported 52-week range, 2.3% below the high.
$29.66-$0.39 (-1.31%)
AllianzIM 6 Month Buffer10 Allocation ETF’s quoted price sits in the lower half of its reported 52-week range, 11.91% below the high.
$39.41-$0.23 (-0.58%)
Touchstone Dividend Select ETF’s quoted price sits in the upper half of its reported 52-week range, 1.77% below the high.
$37.86-$0.15 (-0.41%)
Federated Hermes MDT Large Cap Value ETF’s quoted price sits in the upper half of its reported 52-week range, 1.12% below the high.
$34.17-$1.01 (-2.87%)
Neuberger Berman Japan Equity ETF’s quoted price sits in the lower half of its reported 52-week range, 12.27% below the high.
$27.42+$0.01 (+0.05%)
VictoryShares Hedged Equity Income ETF’s quoted price sits in the upper half of its reported 52-week range, 0.47% below the high.
